AFYA Stock Recent News

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that Mrs. Shobhna Mohn notified the Company of her intent to resign as a member of the Board of Directors of the Company, effective as of June 30, 2024, as she also steps down from her operational role at Bertelsmann, one of the key shareholders of Afya. Mrs. Mohn's decision is unrelated to a.

The average of price targets set by Wall Street analysts indicates a potential upside of 32.8% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that the resolution set out in its Notice of Annual General Meeting dated May 17, 2024 was duly passed at its Annual General Meeting held today: the approval and ratification of Afya's financial statements and the auditor's report for the fiscal year ended December 31, 2023. About Afya Limite.

NOVA LIMA, Brazil--(BUSINESS WIRE)--Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A. (Nasdaq: AFYA; B3: A2FY34) (the "Company"), Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing the following link https://web.lumiconnect.com/283874046 (password: afya2024), on the 5th day of June 2024 at 10:00 a.m. BRT, for the purpose.

Afya Limited (NASDAQ:AFYA ) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Renata Couto - IR Virgilio Gibbon - CEO Luis Andre Blanco - CFO Conference Call Participants Lucca Marquezini - Itau Mirela Oliveira – Bank of America Marcelo Santos - JPMorgan Lucas Nagano - Morgan Stanley Leandro Bastos - Citi Renata Couto Good night, everyone. Thank you for joining us for Afya's First Quarter 2024 Conference Call.

Afya (AFYA) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.34 per share a year ago.

The company's 2023 earnings and revenue were strong, but its stock price has declined significantly. The selloff is largely due to AFYA's declining revenue growth rates. Guidance is also soft, adding to concerns from investors and analysts.

The latest trading day saw Afya (AFYA) settling at $18.13, representing a -1.47% change from its previous close.

Afya is one of the leading private medical education providers in Brazil. The company's model has several quality characteristics including high pricing power, and resiliency to economic cycles. Afya has a significant runway to grow organically and inorganically, via seat expansions, price adjustments and acquisitions.